3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Infections -

Hepatitis B virus capsid-like particles stimulate protective antibody responses

InfectionsSep 19, 06

According to recently published research from Germany, hepatitis B virus (HBV) capsid-like particles (CLPs) can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.

“HBV CLPs, icosahedral assemblies formed by 90 or 120 core protein dimers, hold promise as immune-enhancing vaccine carriers for heterologous antigens. Insertions into the immunodominant c/e1B cell epitope, a surface-exposed loop, are especially immunogenic.

“However, display of whole proteins, desirable to induce multispecific and possibly neutralizing antibody responses, can be restrained by an unsuitable structure of the foreign protein and by its propensity to undergo homomeric interactions,” wrote C. Skamel and colleagues, University of Freiburg Hospital.

“Here we analyzed CLP formation by core fusions with two distinct variants of the dimeric outer surface lipoprotein C (OspC) of the Lyme disease agent B. burgdorferi.

“Although the topology of the termini in the OspC dimer does not match that of the insertion sites in the carrier dimer, both fusions, coreOspC(a) and coreOspC(b), efficiently formed stable CLPs. Electron cryomicroscopy clearly revealed the surface disposition of the OspC domains, possibly with OspC dimerization occurring across different core protein dimers,” the authors reported.

“In mice, both CLP preparations induced high-titered antibody responses against the homologous OspC variant, but with substantial cross-reactivity against the other variant. Importantly, both conferred protection to mice challenged with B. burgdorferi,” the scientists observed.

They concluded, “These data show the principal applicability of hepatitis B virus CLPs for the display of dimeric proteins, demonstrate the presence in OspC of hitherto uncharacterized epitopes, and suggest that OspC, despite its genetic variability, may be a valid vaccine candidate.”

Skamel and colleagues published their study in the Journal of Biological Chemistry (Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection. J Biol Chem, 2006;281(25):17474-17481).

For more information, contact M. Nassal, University of Freiburg Hospital, Institute of Immunology, Hugstetter Str 55, D-79106 Freiburg, Germany.

Publisher contact information for the Journal of Biological Chemistry is: American Society of Biochemistry & Molecular Biology Inc., 9650 Rockville Pike, Bethesda, MD 20814-3996, USA.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Many European countries ill-prepared to prevent and control the spread of viral hepatitis
  HPV vaccination not associated with increase in sexually transmitted infections
  Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention
  To curb hepatitis C, test and treat inmates
  Vinegar kills tuberculosis and other mycobacteria
  New strategy emerges for fighting drug-resistant malaria
  Toys, books, cribs harbor bacteria for long periods, study finds
  California high school to test students for tuberculosis
  TB Vaccine May Work Against Multiple Sclerosis
  Tuberculosis: Nature has a double-duty antibiotic up her sleeve
  Treatment target identified for a public health risk parasite
  Nearly half of U.S. children late receiving vaccines

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site